GlassScriptPhysician profile
Jason Breaux
NPI 1619167517
$55,744.87
in general payments reported to CMS, 2019-2025
30 companies · $6,113 in 2025
The $6,113 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,389 · 2020: $608 · 2021: $5,413 · 2022: $215 · 2023: $27K · 2024: $14K · 2025: $6,113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $41K · Food and Beverage: $3,190 · Travel and Lodging: $2,830 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $40,600.00 |
| Food and Beverage | $3,189.60 |
| Travel and Lodging | $2,830.35 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $51,434.20 | 2019-2025 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $1,202.34 | 2019 | |
| Biom'Up France Sas | $780.08 | 2020-2021 | |
| W. L. Gore & Associates, INC. | $678.04 | 2019-2021 | |
| Ethicon US, LLC | $238.47 | 2019-2025 | Echelon; Endopath |
| Trisalus Life Sciences, INC. | $199.38 | 2024 | Trinav Infusion System |
| Merck Sharp & Dohme LLC | $183.77 | 2021-2025 | Keytruda, Welireg, Lynparza |
| Silk Road Medical, INC. | $160.93 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Sirtex Medical INC | $146.48 | 2022 | |
| Biom'Up Sa | $102.41 | 2019 | |
| Sanara Medtech INC. | $74.00 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.02 | 2025 | Fruzaqla, Alunbrig |
| Eisai INC. | $53.12 | 2021-2024 | |
| Pacira Pharmaceuticals Incorporated | $45.47 | 2024-2025 | Exparel |
| Janssen Biotech, INC. | $37.48 | 2022-2025 | Erleada, Balversa, Akeega |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $34.67 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $32.58 | 2023 | Opdivo |
| Kci USA, INC. | $31.88 | 2020 | |
| Jazz Pharmaceuticals INC. | $30.91 | 2025 | |
| Kerecis Limited | $29.15 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Medtronic, INC. | $28.65 | 2024-2025 | Emprint, Bis |
| Elucent Medical | $27.25 | 2024 | |
| Geron Corporation | $22.61 | 2025 | Rytelo |
| Ipsen Biopharmaceuticals, INC | $21.95 | 2025 | Onivyde, Somatuline Depot |
| Coloplast Corp | $20.17 | 2025 | |
| Pharmacosmos Therapeutics INC. | $19.87 | 2024 | Monoferric |
| Genentech USA, INC. | $18.30 | 2024 | Tecentriq |
| Springworks Therapeutics, INC. | $15.56 | 2024 | Ogsiveo |
| Covidien LP | $11.75 | 2019 | |
| Bolder Surgical LLC | $8.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Breaux listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.